Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Biogen Idec (BIIB)

Add to Watchlists
Create an Alert
302.52 -3.68  -1.20% NASDAQ Apr 23, 3:07PM BATS Real time Currency in USD
View Full Chart
BIIB Price Chart
View All Events

BIIB Events

Date Type Description
Apr 23 Misc Biogen Idec Inc Q1 2014 Earning Conference Call
Apr 23 Earnings Biogen Idec Inc Q1 2014 Earning Result. Estimate: 2.58.
Jan 29 Misc Biogen Idec to Report Fourth Quarter and Year-end 2013 Financial Results on January 29, 2014
Jan 29 Earnings Biogen Idec to Report Fourth Quarter and Year-end 2013 Financial Results. Estimate: 2.22.
Oct 28 Misc Iogen Idec to Report Third Quarter 2013 Financial Results Conference Call
Oct 28 Earnings Biogen Idec to Report Third Quarter 2013 Financial Results on October 28, 2013. Estimate: 2.18.
Sep 09 Misc Isis Pharmaceuticals Conference Call to Discuss Its New Strategic Collaboration With Biogen Idec
Jul 25 Misc Q2 2013 Earnings Conference Call
Jul 25 Earnings Biogen Idec to Report Second Quarter 2013 Financial Results on July 25, 2013. Estimate: 1.76.
Jun 12 Misc AGM Event for Biogen Idec Inc
View All Performance Charts

BIIB Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biogen Idec is up 40.58% over the last year vs S&P 500 Total Return up 22.65%, Gilead Sciences up 37.63%, and Novartis up 22.86%.

Get Quote for

PDF Report for BIIB

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download BIIB Pro Report PDF

Portfolio Strategies Featuring BIIB

Did Biogen Idec make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BIIB Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Biogen Idec, Inc. is a biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer. The company was formed in 2003 by the merger of Cambridge, Massachusetts-based Biogen Inc. and San Diego, California-based IDEC Pharmaceuticals . Biogen, one of the oldest biotechnology companies, was founded in 1978 in Geneva by several biologists, including Phillip Sharp of the Massachusetts Institute of Technology, Walter Gilbert of Harvard and Charles Weissmann of Zurich University .

Recent Quotes

Symbol Price Chg Chg % Market Cap
BIIB 302.52 -3.68 -1.20% 71.51B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.